Inspire Investing’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$87 Sell
3
-4
-57% -$144 ﹤0.01% 1227
2026
Q1
$245 Hold
7
﹤0.01% 1057
2025
Q4
$265 Buy
+7
New +$305 ﹤0.01% 1056
2020
Q2
Sell
-484
Closed -$28K 542
2020
Q1
$28K Buy
+484
New +$44.6K 0.01% 619
2018
Q1
Sell
-838
Closed -$43K 301
2017
Q4
$43K Buy
+838
New +$43.6K 0.04% 744

Other funds holding CNMD

Inspire Investing's CNMD Position: Q2 2026 in Review

Inspire Investing reduced its CONMED (CNMD) stake by 57% in Q2 2026, selling an estimated $144 and leaving 3 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Inspire Investing first reported a position in CNMD in Q4 2017 and has held it in 5 quarters since. The position peaked at $43K in Q4 2017. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Inspire Investing held 3 shares of CONMED worth $87 as of Q2 2026.
  • Inspire Investing sold 4 CONMED shares in Q2 2026, an estimated $144.
  • CONMED made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1227 holding.
  • Inspire Investing first reported a position in CONMED in Q4 2017 and has held it in 5 quarters since.
  • Inspire Investing's CONMED position peaked at $43K in Q4 2017.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.